Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

Effects of Jak2 type 1 inhibitors NVP-BSK805 and NVP-BVB808 on Jak2 mutation-positive and Bcr-Abl-positive cell lines.

Ringel F, Kaeda J, Schwarz M, Oberender C, Grille P, Dörken B, Marque F, Manley PW, Radimerski T, le Coutre P.

Acta Haematol. 2014;132(1):75-86. doi: 10.1159/000356784. Epub 2014 Jan 31.

PMID:
24504330
2.

Modulation of activation-loop phosphorylation by JAK inhibitors is binding mode dependent.

Andraos R, Qian Z, Bonenfant D, Rubert J, Vangrevelinghe E, Scheufler C, Marque F, Régnier CH, De Pover A, Ryckelynck H, Bhagwat N, Koppikar P, Goel A, Wyder L, Tavares G, Baffert F, Pissot-Soldermann C, Manley PW, Gaul C, Voshol H, Levine RL, Sellers WR, Hofmann F, Radimerski T.

Cancer Discov. 2012 Jun;2(6):512-523. doi: 10.1158/2159-8290.CD-11-0324. Epub 2012 May 3.

3.

Smoking habits in sixth year medicine students and antismoking measures in Portugal.

Borges A, Marque F, Lima J, Costa L, Gonçalves P, Fernandes R.

Rev Port Pneumol. 2008 Jul-Aug;14(4):591. doi: 10.1016/S0873-2159(15)30269-5. English, Portuguese. No abstract available.

Supplemental Content

Loading ...
Support Center